Pivotal Research Solutions

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• COPD4 trials
• Asthma2 trials
• Obesity2 trials
• Type 2 diabetes1 trial
• Vitiligo1 trial

Phase

• Phase 24 trials
• Phase 34 trials

Status

• Active, not recruiting4 trials
• Completed4 trials
• Recruiting1 trial

Lead sponsor

• Connect Biopharm LLC2 trials
• Eli Lilly and Company2 trials
• Hoffmann-La Roche2 trials
• Incyte Corporation1 trial
• Philip Morris Products S.A.1 trial
• and 1 more

Running trials

• Active, not recruiting

  A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  NCT07215559· Phase 2· Eli Lilly and Company· Source

• Active, not recruiting

  Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS

  NCT07108166· Philip Morris Products S.A.· Source

• Active, not recruiting

  A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

  NCT06662383· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

  NCT06113445· Phase 3· Incyte Corporation· Source

• Recruiting

  A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

  NCT05878769· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting

Closed trials

• Completed

  Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)

  NCT06940154· Phase 2· Connect Biopharm LLC· Source

• Completed

  Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

  NCT06940141· Phase 2· Connect Biopharm LLC· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

  NCT06196879· Phase 2· Upstream Bio Inc.· Source

• Completed

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· Phase 3· Hoffmann-La Roche· Source